Moving Life Science Innovations along the path
From Discovery To Development To Delivery
OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.
OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.
Arizona’s bioscience industry is growing rapidly with over 34,000 jobs spanning over 2,000 business establishments in 2020. The industry’s job base grew 5.4% in Arizona from 2018-2020, more than tripling the U.S. growth rate of 1.4%. Arizona’s universities conducted nearly $623 million in R&D activities in bioscience-related fields in 2020, fueled in part by steadily increasing NIH awards to Arizona institutions since 2016. Venture capital investments in Arizona bioscience companies increased again in 2021, and during the 2018-2021 period totaled $532 million.
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.
AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.
AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.
Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.
Success Stories – Good News from Arizona’s BioIndustry
The development of a new drug is a long, complicated process involving up to 15 years of research and, in many cases, hundreds of millions of dollars. There are two distinct processes that every drug must go through before reaching the general patient population and treating a specific disease – Drug Discovery and Drug Development.
Regenesis Biomedical Expands Payor Sources to Increase Patient Access with addition of a new Reimbursement and Health Economics Vice President and Expands Leadership Team and Market Reach with a new COO.
Over the last 10 days, I learned a lot about the power of support teams.
AZBio partners with LexisNexis and State Net to bring you all the latest updates from Washington DC and around the nation. Check out the latest in the January 16, 2012 edition.
- Digital RESI & Innovator Pitch Challenge June-- 50% Discount off Registration
- 06/07/2022 - 06/09/2022
- BIO International Convention
- 06/13/2022 - 06/16/2022
- San Diego
- AZBioPEERS: Tales from the Road - Tassos Gianakakos
- Venom Week VIII at SkySong
- 07/18/2022 - 07/21/2022
- AZBioPEERS: Business Basics Series- How To Build An Investable Team